Emodin-loaded polymer lipid hybrid nanoparticles (E-PLNs) exhibited superior anti-cancer efficacy against breast cancer (MCF-7) cells by enhancing uptake, promoting early apoptosis via Bax/Bcl-2 pathway, and inhibiting tumor growth by over 60% in mice. This evidence concerns the gene BCL2 and neoplasm.